Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer⦠read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
$22.67
Price+0.30%
$0.07
$693.846m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$303.223m
-
1y CAGR-
3y CAGR-
5y CAGR-$51.023m
-
1y CAGR-
3y CAGR-
5y CAGR-$1.65
-
1y CAGR-
3y CAGR-
5y CAGR$1.112b
$1.200b
Assets$88.202m
Liabilities$7.386m
Debt0.6%
-0.2x
Debt to EBITDA-$59.952m
-
1y CAGR-
3y CAGR-
5y CAGR